Familial Hypertrophic Cardiomyopathy Latest Advances

CYP450 activity, drug interactions and genetic polymorphisms: clinical relevance for the new selective cardiac myosin inhibitors.

Journal: Expert opinion on drug safety

Published: November 28, 2025

Hypertrophic Cardiomyopathy Mimicking a Primary Cardiac Tumor: Case Report and Review of Molecular Genetic Findings.

Journal: The American journal of forensic medicine and pathology

Published: November 17, 2025

Hypertrophic Cardiomyopathy: The Impact of Age at Diagnosis of the Proband on Genetic Yield, Clinical Presentation, Outcomes, and Yield of Family Screening.

Journal: Journal of the American Heart Association

Published: November 06, 2025

Identification of novel genetic variants in hypertrophic cardiomyopathy.

Journal: Cardiology in the young

Published: October 20, 2025

Uncovering genetic architecture of the heart via genetic association studies of unsupervised deep learning derived endophenotypes.

Journal: bioRxiv : the preprint server for biology

Published: September 26, 2025

Genetic, Clinical, and Sociodemographic Profile of Individuals with Diagnosis or Family History of Hypertrophic Cardiomyopathy: Insights from a Prospective Cohort.

Journal: Genes

Published: August 31, 2025

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate Effect Variants.

Journal: Circulation

Published: August 29, 2025

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants.

Journal: Circulation

Published: August 29, 2025

Novel Cardiac Troponin-I Missense Variant (c.593C>T) Is Associated With Familial Hypertrophic Cardiomyopathy in Golden Retrievers.

Journal: Circulation. Genomic and precision medicine

Published: August 22, 2025

Discovering Genetic Variants in Hypertrophic Cardiomyopathy With Multiple Machine Learning Techniques.

Journal: IEEE transactions on computational biology and bioinformatics

Published: August 14, 2025

Clinical manifestations, genetic profiles, and sudden cardiac arrest in pediatric hypertrophic cardiomyopathy: Challenges of risk prediction for initial sudden cardiac arrest presentations.

Journal: Heart rhythm O2

Published: July 30, 2025

Reconsidering the causal role of cardiovascular risk factors in genotype-negative hypertrophic cardiomyopathy: The importance of polygenic inheritance and genetic architecture.

Journal: International journal of cardiology

Published: July 09, 2025

Filters

CYP450 activity, drug interactions and genetic polymorphisms: clinical relevance for the new selective cardiac myosin inhibitors.

CYP450 activity, drug interactions and genetic polymorphisms: clinical relevance for the new selective cardiac myosin inhibitors.

Hypertrophic Cardiomyopathy Mimicking a Primary Cardiac Tumor: Case Report and Review of Molecular Genetic Findings.

Hypertrophic Cardiomyopathy Mimicking a Primary Cardiac Tumor: Case Report and Review of Molecular Genetic Findings.

Hypertrophic Cardiomyopathy: The Impact of Age at Diagnosis of the Proband on Genetic Yield, Clinical Presentation, Outcomes, and Yield of Family Screening.

Hypertrophic Cardiomyopathy: The Impact of Age at Diagnosis of the Proband on Genetic Yield, Clinical Presentation, Outcomes, and Yield of Family Screening.

Identification of novel genetic variants in hypertrophic cardiomyopathy.

Identification of novel genetic variants in hypertrophic cardiomyopathy.

Uncovering genetic architecture of the heart via genetic association studies of unsupervised deep learning derived endophenotypes.

Uncovering genetic architecture of the heart via genetic association studies of unsupervised deep learning derived endophenotypes.

Genetic, Clinical, and Sociodemographic Profile of Individuals with Diagnosis or Family History of Hypertrophic Cardiomyopathy: Insights from a Prospective Cohort.

Genetic, Clinical, and Sociodemographic Profile of Individuals with Diagnosis or Family History of Hypertrophic Cardiomyopathy: Insights from a Prospective Cohort.

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate Effect Variants.

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate Effect Variants.

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants.

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants.

Novel Cardiac Troponin-I Missense Variant (c.593C>T) Is Associated With Familial Hypertrophic Cardiomyopathy in Golden Retrievers.

Novel Cardiac Troponin-I Missense Variant (c.593C>T) Is Associated With Familial Hypertrophic Cardiomyopathy in Golden Retrievers.

Discovering Genetic Variants in Hypertrophic Cardiomyopathy With Multiple Machine Learning Techniques.

Discovering Genetic Variants in Hypertrophic Cardiomyopathy With Multiple Machine Learning Techniques.

Clinical manifestations, genetic profiles, and sudden cardiac arrest in pediatric hypertrophic cardiomyopathy: Challenges of risk prediction for initial sudden cardiac arrest presentations.

Clinical manifestations, genetic profiles, and sudden cardiac arrest in pediatric hypertrophic cardiomyopathy: Challenges of risk prediction for initial sudden cardiac arrest presentations.

Reconsidering the causal role of cardiovascular risk factors in genotype-negative hypertrophic cardiomyopathy: The importance of polygenic inheritance and genetic architecture.

Reconsidering the causal role of cardiovascular risk factors in genotype-negative hypertrophic cardiomyopathy: The importance of polygenic inheritance and genetic architecture.